Collegium Pharmaceutical (COLL) FCF Margin (2016 - 2026)

Collegium Pharmaceutical's FCF Margin history runs 11 years deep, the most recent figure standing at 29.37% for Q1 2026.

• In Q1 2026, FCF Margin fell 134.0% year-over-year to 29.37%; the TTM figure through Mar 2026 stood at 41.6% (up 328.0% YoY), while the FY2025 annual figure was 42.15%, up 995.0% from the prior year.
• FCF Margin was 29.37% for Q1 2026 at Collegium Pharmaceutical, down from 59.89% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 73.53% in Q2 2023 to a low of 699.39% in Q1 2022.
• Historically, FCF Margin has averaged 10.6% across 5 years, with a median of 38.89% in 2025.
• The sharpest annual moves came in 2022 and 2023: FCF Margin sank 72236 bps in 2022, then soared 71839 bps in 2023.
• A 5-year view of FCF Margin shows it stood at 50.44% in 2022, then declined by 3 bps to 48.87% in 2023, then fell by 5 bps to 46.21% in 2024, then climbed by 30 bps to 59.89% in 2025, then sank by 51 bps to 29.37% in 2026.
• The last three FCF Margin figures came in at 29.37% (Q1 2026), 59.89% (Q4 2025), and 37.37% (Q3 2025), per Business Quant data.